| Earnings Per Share |
Note
7 – Earnings Per Share
Basic
net loss per share is computed by dividing reported net loss by the weighted-average number of common shares outstanding for the reported
period. In computing diluted earnings per share, common share equivalents are not considered in periods in which a net loss is reported,
as the inclusion of the common share equivalents would be antidilutive. Since the Company was in a net loss for all periods presented
in these consolidated financial statements, diluted net loss per share was the same as basic net loss per share.
Schedule
of Earnings Per Share Basic and Diluted
| | |
| | | |
| | | |
| | | |
| | |
| | |
Three Months Ended
September 30, | | |
Nine Months Ended
September 30, | |
| (in thousands, except per share data) | |
2025 | | |
2024 | | |
2025 | | |
2024 | |
| Numerator: | |
| | |
| | |
| | |
| |
| Net loss attributable to common stockholders | |
$ | (2,634 | ) | |
$ | (2,977 | ) | |
$ | (7,831 | ) | |
$ | (7,969 | ) |
| Denominator: | |
| | | |
| | | |
| | | |
| | |
| Weighted-average common shares outstanding | |
| 3,174 | | |
| 2,924 | | |
| 3,043 | | |
| 2,924 | |
| | |
| | | |
| | | |
| | | |
| | |
| Net loss per common share | |
$ | (0.83 | ) | |
$ | (1.02 | ) | |
$ | (2.57 | ) | |
$ | (2.73 | ) |
The
following potential common share equivalents were excluded from the calculation of diluted net income per share because their effect
would have been anti-dilutive in the period presented (in thousands):
Schedule
of Antidilutive Securities Earnings Per Share
| | |
2025 | | |
2024 | |
| | |
Nine Months Ended
September 30, | |
| | |
2025 | | |
2024 | |
| Convertible preferred stock | |
| 31,206 | | |
| 25,247 | |
| Common Stock Warrants | |
| 1,421 | | |
| - | |
| Preferred Stock Warrants | |
| 247 | | |
| 247 | |
| Stock options | |
| 7,050 | | |
| 5,027 | |
| Total potential common stock excluded from net loss per share | |
| 39,924 | | |
| 30,521 | |
|
Note
7 – Earnings Per Share
Basic
net loss per share is computed by dividing reported net loss by the weighted-average number of common shares outstanding for the reported
period. In computing diluted earnings per share, common share equivalents are not considered in periods in which a net loss is reported,
as the inclusion of the common share equivalents would be antidilutive. Since the Company was in a net loss for all periods presented
in these consolidated financial statements, diluted net loss per share was the same as basic net loss per share.
Schedule
of Earnings Per Share Basic and Diluted
| | |
2024 | | |
2023 | |
| | |
Years
Ended December
31, | |
| | |
2024 | | |
2023 | |
| Numerator: | |
(in
thousands, except per share data) | |
| Net
loss attributable to common stockholders | |
$ | (11,017 | ) | |
$ | (12,257 | ) |
| Denominator: | |
| | | |
| | |
| Weighted-average
common shares outstanding | |
| 2,938 | | |
| 1,180 | |
| | |
| | | |
| | |
| Net loss per common
share | |
$ | (3.75 | ) | |
$ | (10.39 | ) |
TG-17
INC.
NOTES
TO THE CONSOLIDATED FINANCIAL STATEMENTS
The
following potential common share equivalents were excluded from the calculation of diluted net income per share in FY 2024 because their
effect would have been anti-dilutive in the period presented (in thousands):
Schedule
of Antidilutive Securities Earnings Per Share
| | |
2024 | | |
2023 | |
| | |
Years
Ended December
31, | |
| | |
2024 | | |
2023 | |
| Convertible
preferred stock | |
| 26,560 | | |
| 22,460 | |
| Stock
options | |
| 5,027 | | |
| 178 | |
| Total
potential common stock excluded from net loss per share | |
| 31,587 | | |
| 22,638 | |
|